• Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease 

      Al Said S., Ellscheid M., Beltsios E.T., Frey N. (2022)
      The prevention of atherothrombotic events is the primary goal in the treatment of patients with arteriosclerotic disorders. Despite recent improvements in the management of coronary artery disease (CAD) with revascularization ...